SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-24-044367
Filing Date
2024-04-05
Accepted
2024-04-05 17:25:44
Documents
16
Period of Report
2024-04-05
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2411224d1_8k.htm   iXBRL 8-K 30087
2 EXHIBIT 1.1 tm2411224d1_ex1-1.htm EX-1.1 230917
3 EXHIBIT 5.1 tm2411224d1_ex5-1.htm EX-5.1 14151
7 GRAPHIC tm2411224d1_ex5-1img001.jpg GRAPHIC 3540
  Complete submission text file 0001104659-24-044367.txt   515072

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA nnvc-20240405.xsd EX-101.SCH 3030
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE nnvc-20240405_lab.xml EX-101.LAB 34240
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE nnvc-20240405_pre.xml EX-101.PRE 22369
19 EXTRACTED XBRL INSTANCE DOCUMENT tm2411224d1_8k_htm.xml XML 3525
Mailing Address 1 CONTROLS DRIVE SHELTON CT 06484
Business Address 1 CONTROLS DRIVE SHELTON CT 06484 (203) 937-6137
NANOVIRICIDES, INC. (Filer) CIK: 0001379006 (see all company filings)

IRS No.: 760674577 | State of Incorp.: NV | Fiscal Year End: 0630
Type: 8-K | Act: 34 | File No.: 001-36081 | Film No.: 24827553
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)